is semaglutide going off the market FDA crackdown on off-brand Ozempic products set to take effect, threatening supply and access for many Liraglutide and Semaglutide Market Share

These included Eli Lillys expanded approval of Mounjaro in obesity (approved as Zepbound), CRISPR Therapeutics gene editing treatment for sickle cell disease, and Sarepta Therapeutics gene therapy for Duchenne muscular dystrophy

38 Receptor-mediated and lipid-driven mitophagy pathways in the heart Beyond PINK1-Parkin, FUNDC1 has emerged as a key mitophagy regulator, particularly under hypoxia

95% CI: 0.540.93

These immunological alterations which have characterized our current understanding of Covid-19 suggest that agents which target immune modulation, rather than direct viricidal activity, may present exciting targets for pharmacological intervention

BMJ, 2021

This regimen may be appropriate for patients who have struggled to shed pounds and keep them off by following conventional methods, have developed obesity-related health challenges, or need a systematic, monitored approach to weight loss